3 hours Immunocore (NASDAQ:IMCR) Downgraded to Neutral at Guggenheim MarketBeat
Guggenheim cut shares of Immunocore from a “buy” rating to a “neutral” rating in a research note on Monday.
Guggenheim cut shares of Immunocore from a “buy” rating to a “neutral” rating in a research note on Monday.